We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration
News

Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration

Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration
News

Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Thrombotargets Corp and Instituto Biomar have announced the signature of a drug discovery collaboration agreement.

Under the terms of this agreement, Instituto Biomar will provide Thrombotargets Corp with its libraries of purified natural products and extracts collection for its High Throughput Screening of Pathway Activity (HTS-PA) in Thrombotargets’ technology.

Thrombotargets will seek to identify and optimize drug candidates for multiple targets that will be jointly developed by both companies.

Advertisement